Katherine Jonckheere recently authored a case commentary published by the Belgian Review of Arbitration (b-Arbitra), which is available on Kluwer Arbitration. The article discusses the Brussels Court of Appeal 12 November 2019 decision to allow enforcement of a 2008 commercial arbitration award in favour of the blood plasma company, Diag Human, a decision that is significant, as it represents a rare victory for the Liechtenstein company among numerous unsuccessful enforcement attempts in other countries. The commentary examines how the Belgian judgment differs from the foreign court decisions that have dealt with the same issues and whether it would have been preferable for the Belgian court to have taken those decisions into consideration in its decision making.

For access to the full commentary, please click here to subscribe to Kluwer Arbitration.


Katherine, an associate in the London office, specialises in international commercial arbitration and investor-State disputes. She has experience working on high-value and complex arbitrations governed by a variety of arbitration rules and across several industries, including the energy sector.

Katherine’s recent experience includes representing various leading oil and gas companies in disputes against several States in the CIS region, the Middle East, and Africa, relating to matters such as tax, production sharing, and cost recovery. She was also part of the team that successfully defended clients against multibillion-dollar counterclaims from the Kurdistan Regional Government in Iraq.


« Back